IMAX (IMAX) CEO Gelfond reports performance share conversions and tax withholding

Rhea-AI Filing Summary

IMAX CORP Chief Executive Officer Richard L. Gelfond reported compensation-related equity transactions in common shares. He acquired 196,964 common shares upon conversion of vested performance stock units tied to EBITDA performance conditions and 91,768 common shares from units tied to TSR performance conditions, both originally granted on January 2, 2023. To satisfy tax withholding obligations on these conversions, 159,670 common shares were withheld at a price of $40.80 per share. Following these transactions, he directly holds 765,002 common shares, with additional remaining outstanding option, restricted share unit and common share balances of 1,818,695 options, 231,562 restricted share units and 765,002 common shares, respectively.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider GELFOND RICHARD L

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	common shares	196,964	$0.00	--
Grant/Award	common shares	91,768	$0.00	--
Tax Withholding	common shares	159,670	$40.80	$6.51M
holding	common shares (opening balance)	--	--	--

Holdings After Transaction: common shares — 832,904 shares (Direct); common shares (opening balance) — 635,940 shares (Direct)

Footnotes (1)

1. Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three-year performance period. Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the TSR performance conditions over the three-year performance period. Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the performance stock units. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695, 231,562 and 765,002, respectively.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GELFOND RICHARD L

(Last) (First) (Middle)

902 BROADWAY

20TH FLOOR

(Street)

NEW YORK 10010-6002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								635,940	D
common shares	03/07/2026		A		196,964(1)	A	$0.00	832,904	D
common shares	03/07/2026		A		91,768(2)	A	$0.00	924,672	D
common shares	03/07/2026		F		159,670(3)	D	$40.8	765,002(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three-year performance period.

2. Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the TSR performance conditions over the three-year performance period.

3. Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the performance stock units.

4. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695, 231,562 and 765,002, respectively.

Remarks:

	/s/ Richard L. Gelfond	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity transactions did IMAX (IMAX) CEO Richard Gelfond report on this Form 4?

Richard Gelfond reported equity awards converting into common shares and related tax withholding. He received 196,964 shares from EBITDA-based performance stock units and 91,768 shares from TSR-based units granted on January 2, 2023, plus a share withholding transaction to cover taxes.

Were the IMAX (IMAX) CEO’s reported transactions open-market buys or sells?

The reported transactions were not open-market buys or sells. They involved the conversion of vested performance stock units into common shares and a tax-withholding disposition, where shares were withheld by IMAX Corporation to satisfy tax obligations on those equity awards.

How many IMAX (IMAX) common shares were withheld for taxes in this filing?

IMAX withheld 159,670 common shares from Richard Gelfond to satisfy tax obligations. The withholding occurred in connection with the delivery of common shares upon conversion of his performance stock units and was priced at $40.80 per share in the reported transaction.

What are Richard Gelfond’s IMAX (IMAX) share and award balances after these transactions?

After these transactions, Richard Gelfond’s aggregate remaining balances are 1,818,695 stock options, 231,562 restricted share units and 765,002 common shares. These figures reflect his remaining outstanding equity awards and direct common share holdings as disclosed in the Form 4 footnotes.

What performance conditions determined the IMAX (IMAX) performance stock units that converted to shares?

The performance stock units converted based on three-year performance. One grant depended on EBITDA performance conditions and another on TSR performance conditions, both measured over a three-year performance period following the January 2, 2023 grant date disclosed in the footnotes.

How many IMAX (IMAX) common shares did the CEO acquire through performance stock unit conversions?

Richard Gelfond acquired 196,964 common shares from vested performance stock units tied to EBITDA conditions and 91,768 common shares from units tied to TSR conditions. Both groups of units were originally granted on January 2, 2023 and vested based on three-year performance results.